Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor XIIIa expression in juvenile xanthogranuloma

L Misery1, S Boucheron, A L Claudy

  • 1Department of Dermatology, University Hospital, Saint Etienne, France.

Acta Dermato-Venereologica
|January 1, 1994
PubMed
Summary

Juvenile xanthogranulomas are primarily composed of dermal dendrocytes, not Langerhans cells or macrophages. This finding suggests dermal dendrocytes may link juvenile xanthogranuloma to dermatofibroma in a benign tumor continuum.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicidal ideation in patients with skin conditions: A multicentre European study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Validation of the French translation of the Prurigo Control Test (PCT) questionnaire.

Annales de dermatologie et de venereologie·2026
Same author

Pseudolymphoma following laser removal of red tattoo ink.

Annales de dermatologie et de venereologie·2026
Same author

Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Annales de dermatologie et de venereologie·2025
Same author

Validation of the French version of the hidradenitis suppurativa quality of life (HiSQOL) questionnaire.

Annales de dermatologie et de venereologie·2025

Area of Science:

  • Dermatopathology
  • Immunohistochemistry
  • Cell Biology

Background:

  • Dermatofibromas are characterized by dermal dendrocytes.
  • The cellular origin of histiocytic tumors like juvenile xanthogranuloma remains unclear.
  • Investigating cell populations in juvenile xanthogranuloma is crucial for understanding its nature.

Purpose of the Study:

  • To determine the presence and characteristics of dermal dendrocytes in juvenile xanthogranulomas.
  • To differentiate juvenile xanthogranuloma cells from other cell types using immunohistochemistry.
  • To explore the potential relationship between juvenile xanthogranuloma and dermatofibroma.

Main Methods:

  • Immunohistochemical analysis of 9 juvenile xanthogranuloma samples.
  • Utilized antibodies including anti-XIIIa, HAM56, anti-S100, anti-NSE, anti-HLA-DR, anti-CD68, and anti-lysozyme.

Related Experiment Videos

  • Evaluated the expression of specific cell markers on various cell types within the tumors.

    • Main Results:

    • Juvenile xanthogranuloma cells (histiocytes, giant cells, Touton cells) did not express Langerhans cell markers (S100, NSE, HLA-DR).
    • These cells showed weak expression of macrophage markers (CD68, lysozyme).
    • Strong expression of HAM56 and anti-XIIIa was observed, indicating a high presence of dermal dendrocytes, particularly in xanthomatous and early-stage tumors.

    Conclusions:

    • The predominant cell population in juvenile xanthogranulomas consists of dermal dendrocytes.
    • These findings suggest dermal dendrocytes are key cells in a spectrum of benign tumors, potentially linking juvenile xanthogranuloma to dermatofibroma.
    • The cellular composition varies with tumor stage, reflecting different proportions of dendrocytes, lymphocytes, and fibroblasts.